Since 4-1BB is expressed on activated CD8+ T cells, this approach was designed to decrease IL-2 signaling specifically on these cells (Figure 2B).Indeed, this aptamer increased “central memory” phenotype cellsin vitro and enhanced tumor rejection in mice, demonstrating its potential efficacy64. The gene discussed is CD8A; the disease is neoplasm.